EUVIMEDEUVIMED entdecken
Crossref

A narrow-bandgap RuI3 nanoplatform to synergize radiotherapy, photothermal therapy, and thermoelectric dynamic therapy for tumor eradication

Lingjian Zhang, Lingzhou Zhao, Hongxing Su, Yusheng Chen, Wenqing Wang, Mengluan Gao, Jinhua Zhao, Junqing Hu, Rujia Zou

Acta Biomaterialia · 2024

DOI: 10.1016/j.actbio.2024.05.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2024. Verfasst von Lingjian Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, Donghua University, Sha…. Hauptthemen laut MEDLINE: Photothermal Therapy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic resistance is an essential challenge for nanotherapeutics. Herein, a narrow bandgap RuI3 nanoplatform has been constructed firstly to synergize radiotherapy (RT), photothermal therapy (PTT), and thermoelectric dynamic therapy (TEDT) for tumor eradication. Specifically, the photothermal performance of RuI3 can ablate tumor cells while inducing TEDT. Noteworthy, the thermoelectric effect is found firstly in RuI3, which can spontaneously generate an electric field under the temperature gradient, prompting carrier separation and triggering massive ROS generation, thus aggravating oxidative stress level and effectively inhibiting HSP-90 expression. Moreover, RuI3 greatly enhances X-ray deposition owing to its high X-ray attenuation capacity, resulting in a pronounced computed tomography imaging contrast and DNA damage. In addition, RuI3 possesses both catalase-like and glutathione peroxidase-like properties, which alleviate tumor hypoxia and reduce antioxidant resistance, further exacerbating 1O2 production during RT and TEDT. This integrated therapy platform combining PTT, TEDT, and RT significantly inhibits tumor growth. STATEMENT OF SIGNIFICANCE: RuI3 nanoparticles were synthesized for the first time. RuI3 exhibited the highest photothermal properties among iodides, and the photothermal conversion efficiency was 53.38 %. RuI3 was found to have a thermoelectric effect, and the power factor could be comparable to that of most conventional thermoelectric materials. RuI3 possessed both catalase-like and glutathione peroxidase-like properties, which contributed to enhancing the effect of radiotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Photothermal TherapyAnimalsHumansMiceCell Line, TumorMice, Inbred BALB CNanoparticlesNeoplasmsMice, NudeCombined Modality TherapyHyperthermia, InducedRadiotherapyReactive Oxygen Species

Stichwörter der Autor:innen

Catalase-like and glutathione peroxidase-likeHSP-90Photothermal therapyRadiotherapyThermoelectric dynamic therapy

Substanzen

Reactive Oxygen Species

Autor:innen und Institutionen

  • State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, Donghua University, Shanghai 201620, China.
  • Department of Nuclear Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.
  • Department of Nuclear Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China. Electronic address: zhaojinhua1963@126.com.
  • College of Health Science and Environmental Engineering, Shenzhen Technology University, Shenzhen 518118, China. Electronic address: hujunqing@sztu.edu.cn.
  • State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, Donghua University, Shanghai 201620, China; Engineering Research Center of Advanced Glass Man…

Förderung

  • Fundamental Research Funds for the Central Universities
  • Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, L., Zhao, L., Su, H., Chen, Y., Wang, W., Gao, M., Zhao, J., Hu, J., & Zou, R. (2024). A narrow-bandgap RuI3 nanoplatform to synergize radiotherapy, photothermal therapy, and thermoelectric dynamic therapy for tumor eradication. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2024.05.013

Vancouver

Zhang L, Zhao L, Su H, Chen Y, Wang W, Gao M, et al. A narrow-bandgap RuI3 nanoplatform to synergize radiotherapy, photothermal therapy, and thermoelectric dynamic therapy for tumor eradication. Acta Biomaterialia. 2024. doi:10.1016/j.actbio.2024.05.013

BibTeX
@article{Zhang2024,
  author = {Zhang, Lingjian and Zhao, Lingzhou and Su, Hongxing and Chen, Yusheng and Wang, Wenqing and Gao, Mengluan and Zhao, Jinhua and Hu, Junqing and Zou, Rujia},
  title = {A narrow-bandgap RuI3 nanoplatform to synergize radiotherapy, photothermal therapy, and thermoelectric dynamic therapy for tumor eradication},
  journal = {Acta Biomaterialia},
  year = {2024},
  doi = {10.1016/j.actbio.2024.05.013}
}
Kostenlos starten →